Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis

Kidney International

Volumn 49, Issue 1, 1996, Pages 236-243

  Tielemans, Christian ^a   Husson, Cécile ^b   Schurmans, Thierry ^b   Gastaldello, Karine ^b   Madhoun, Philippe ^b   Delville, Jean Pierre ^b   Marchant, Arnaud ^b   Goldman, Michel ^b   Vanherweghem, Jean Louis ^b  

^a ERASME HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID;

ARTICLE; BACTERIUM CONTAMINATION; CONTROLLED STUDY; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL;

EID: 0030053448     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.33     Document Type: Article

References (45)

1. HENDERSON LW, KOCH KM, DINARELLO CA, SHALDON S: Hemodialysis hypotension: The interleukin hypothesis. Blood Purif 1:3-8, 1983
2. BINGEL M, LONNEMANN G, SHALDON S, KOCH KM, DINARELLO CA: Human interleukin-1 production during hemodialysis. Nephron 43: 161-163, 1986
3. PORT FK, VANDEKERKHOVE KM, KUNKEL SL, KLUGER MJ: The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis. Am J Kidney Dis 10:118-122, 1987
4. LONNEMANN G, BINGEL M, FLOEGE J, KOCH KM, SHALDON S, DINARELLO CA: Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 33:29-35, 1988
5. LAUDE-SHARP M, CAROFF M, SIMARD L, PUSINERI C, KAZATCHKINE MD, HAEFFNER-CAVAILLON N: Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS). Kidney Int 38: 1089-1094, 1990
6. BAMBAUER R, WALTHER J, MEYER S, OST S, SCHAUER M, JUNG WK, GǑHL H, VIENKEN J: Bacteria- and endotoxin-free dialysis fluid for use in chronic hemodialysis. Artif Organs 18:188-192, 1994
7. QUELLHORST E, SCHÜNNEMAN B: Beta-2 amyloidosis and haemofiltration, in Dialysis Amyloidosis, edited by GEJYO F, BRANCACCIO D, BARDIN T, Milano, Wichtig Editore, 1989, p 123 (need author's initials)
8. BAZ M, DURAND C, JABER K, ANDRIEU D, NERZOUK T, BERLAND Y: The impact of 12 years of ultrapure dialysate use on hemodialysis related amyloidosis. (abstract) Int J Artif Organs 13:547, 1990
9. BAMBAUER R, WALTHER J, JUNG WK: Ultrafiltration of dialysis fluid to obtain a sterile solution during hemodialysis. Blood Purif 8:309-317, 1990
10. DINARELLO CA, LONNEMANN G, MAXWELL R, SHALDON S: Ultrafiltration to reject human interleukin-1-inducing substances derived from bacterial cultures. J Clin Microbiol 25:1233-1238, 1987
11. PEARSON FC, BOHON J, LEE W, BRUSZER G, SAGONA M, JAKUBOWSKI G, DAWE R, MORRISON D, DINARELLO C: Characterization of Limulus amoebocyte lysate-reactive material from hollow-fiber dialyzers. Appl Environ Microbiol 48:1189-1196, 1984
12. HAEFFNER-CAVAILLON N, CAVAILLON JM, CIANCONI C, BACLE F, DELONS S, KAZATCHKINE MD: In vivo induction of interleukin-1 during hemodialysis. Kidney Int 35:1212-1218, 1989
13. TIELEMANS CL, DELVILLE J-PC, HUSSON CP, MADHOUN P, LAMBRECHTS AM, GOLDMAN M, VANHERWEGHEM J-L: Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol 39:158-165, 1993
14. ELIN RJ, SANDBERG AL, ROSENSTREICH DL: Comparison of the pyrogenicity, limulus activity, mitogenicity and complement reactivity of several bacterial endotoxins and related compouds. J Immunol 117:1238-1242, 1976
15. DINARELLO CA, KRUEGER JM: Induction of interleukin-1 by synthetic and naturally occurring muramyl peptides. Fed Proc 45:2545-2548, 1986
16. MCLEISH KR, WELLHAUSEN SR, DEAN WL: Biochemical basis of HLA-DR and CR3 modulation on human peripheral blood monocytes by lipopolysaccharide. Cell Immunol 108:242-248, 1987
17. WERFEL T, SONNTAG G, WEBER MH, GOTZE O: Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fcγ-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 147:3909-3914, 1991
18. URENA P, HERBELIN A, ZINGRAFF J, LAIR M, MAN NK, DESCAMPS-LATSCHA B, DRUEKE T: Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant 7:16-28, 1992
19. CHENOWETH DE, CHEUNG AK, HENDERSON LW: Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int 24:764-769, 1983
20. CHEUNG AK, PARKER CJ, WILCOX LA, JANATOVA J: Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan. Kidney Int 37:1055-1059, 1990
21. BLAND LA, OLIVER JC, ARDUINO MJ, OETTINGER CW, MCALLISTER SK, FAVERO MS: Potency of endotoxin from bicarbonate dialysate compared with endotoxins from Escherichia coli and Shigella flexneri. J Am Soc Nephrol 5:1634-1637, 1994
22. KLEIN E, PASS T, HARDING GB, WRIGHT R, MILLION C: Microbial and endotoxin contamination in water and dialysate in the central United States. Artif Organs 14:85-94, 1990
23. OETTINGER CW, ARDUINO MJ, OLIVER JC, BLAND LA: The clinical relevance of dialysate sterility. Semin Dial 7:263-267, 1994
24. SCHINDLER R, MARRA MN, MCKELLIGON BM, LONNEMANN G, SCHULZECK P, SCHULZE M, OPPERMANN M, SHALDON S: Plasma levels of bactericidal/permeability increasing protein (BPI) and lipopolysaccharide binding protein (LBP) during hemodialysis. Clin Nephrol 40:346-351, 1993
25. LUGER A, KOVARIK J, STUMVOLL HK, URBANSKA A, LUGER TA: Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32:84-88, 1987
26. OKUSAWA S, DINARELLO CA, YANCEY KB, ENDRES S, LAWLEY TJ, FRANK MM, BURKE JF, GELFAND JA: C5a induction of human interleukin-1: Synergistic effect with endotoxin or interferon-γ. J Immunol 139:2635-2640, 1987
27. SCHINDLER R, GELFAND JA, DINARELLO CA: Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: Transcriptional signal provided by lipopolysaccharide or IL-1 itself. Blood 76:1631-1638, 1990
28. HERBELIN A, NGUYEN AT, URENA P, DESCAMPS-LATSCHA B: Induction of cytokines by dialysis membranes in normal whole blood: A new in vitro assay for evaluating membrane bincompatibility. Blood Purif 10:40-52, 1992
29. GHYSEN J, DE PLAEN JF, VAN YPERSELE DE STRIHOU: The effect of membrane characteristics on tumor necrosis factor kinetics during haemodialysis. Nephrol Dial Transplant 5:270-274, 1990
30. SPRINGER TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990
31. ARNAOUT MA, SPITS H, TERHORST C, PITT J, TODD RF III: Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo 1 deficiency. Effects of cell activation on Mo 1/LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest 74:1291-1300, 1984
32. TODD RF III, ARNAOUT MA, ROSIN RE, CROWLEY CA, PETERS WA, BABIOR BM: Subcellular localization of the large subunit of Mo 1 (Mo 1α; formerly gp110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest 74:1280-1290, 1984
33. KISHIMOTO TK, LARSON RS, CORBI AL, DUSTIN ML, STAUNTON DE, SPRINGER TA: The leukocyte integrins. Adv Immunol 46:149-182, 1989
34. DIAMOND MS, STAUNTON DE, DE FOUGEROLLES AR, STACKER SA, GARCIA-AGUILAR J, HIBBS ML, SPRINGER TA: ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 111:3129-3139, 1990
35. THOMAS ML: The leukocyte common antigen family. Ann Rev Immunol 3:339-369, 1989
36. WEBB DSA, SHIMIZU Y, VAN SEVENTER GA, SHAW S, GERRARD TL: LFA-3, CD44, and CD45: Physiologic triggers of human monocyte TNF and IL-1 release. Science 249:1295-1297, 1990
37. KING PD, BATCHELOR AH, LAWLOR P, KATZ DR: The role of CD44, CD45, CD45RO, CD46, and CD55 as potential anti-adhesion molecules involved in the binding of human tonsilar T cells to phorbol 12-myristate 13-acetate-differentiated U-937 cells. Eur J Immunol 20:363-368, 1990
38. ARNAOUT MA, HAKIM RM, TODD RF III, DANA N, COLTEN HR: Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hcmodialysis. N Engl J Med 312:457-462, 1985
39. HIMMELFARB J, ZAOUI P, HAKIM R: Modulation of granulocyte LAM-1 and Mac-1 during dialysis - A prospective, randomized controlled trial. Kidney Int 41:388-395, 1992
40. ALVAREZ V, PULIDO R, CAMPANERO MR, PARAISO V, DE LANDAZURI MO, SANCHEZ-MADRID F: Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int 40:899-905, 1991
41. LUNDHAL J, HED J, JACOBSON SH: Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glucoprotein Mac-1. Nephron 61:163-169, 1992
42. CRISTOL JP, CANAUD B, RABESANDRATANA H, GAILLARD I, SERRE A, MION C: Enhancement of reactive oxygen species production and cell surface markers expression due to hemodialysis. Nephrol Dial Transplant 9:389-394, 1994
43. PULIDO R, ALVAREZ V, MOLLINEDO F, SANCHEZ-MADRID F: Biochemical and functional characterization of the leucocyte tyrosine phosphatase CD45 (CD45RO, 180 kD) from human neutrophils. In vivo upregulation of CD45RO plasma membrane expression in patients undergoing haemodialysis. Clin Exp Immunol 87:329-335, 1992
44. CRADDOCK PR, FEHR J, DALMASSO AP, BRIGHAM KL, JACOBS HS: Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59:879-888, 1977
45. CHEUNG AK, HOHNHOLT M, GILSON M: Adherence of neutrophils to hemodialysis membranes: Role of complement receptors. Kidney Int 40:1123-1133, 1991